Far from the “anti-aging” hype, our aim is to develop truly efficient formulas to prevent and reduce aging signs; we act at the molecular level on aging mechanisms in order to provide a new generation of nutraceuticals dedicated to extend human lifespan. Our team of scientists specialized in bioinformatics, genetics and pharmacology uses AI to analyze combinations of thousands of molecules in order to define adequate dosage and optimal absorption while targeting the largest synergetic effects. Data is pooled from pharmacological and genomic databases, then molecules are selected through the analysis of thousands of peer-reviewed scientific publications and validated through in silico experiments involving biochemical pathways databases. We are constantly designing new products and have a dozen formulas in the pipeline. Our company is open to partnerships with third parties to develop custom-made products according to their needs. As we are working with tools pertaining to the pharmaceutical industry, the scope of our candidate molecules is not limited to nutraceuticals but also encompasses pharma-leads. We are therefore developing a pharma-oriented spin-off project dedicated to preclinical pharmaceutical research.